5-HT modifiers as a potential treatment of asthma
- 1 January 2000
- journal article
- editorial
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (1), 13-16
- https://doi.org/10.1016/s0165-6147(99)01408-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholineBritish Journal of Pharmacology, 1999
- Increased Levels of Free Serotonin in Plasma of Symptomatic Asthmatic PatientsAnnals of Allergy, Asthma & Immunology, 1996
- Epinastine (WAL 801CL) modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptorEuropean Respiratory Journal, 1996
- Droperidol inhibits tracheal contraction induced by serotonin, histamine or carbachol in guinea pigsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1996
- Effects of serotonin on airways: recent developmentsAllergy, 1995
- Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissueLife Sciences, 1994
- Effect of ketanserin, a new blocking agent of the 5-HT2receptor, on airway responsiveness in asthmaAllergy, 1990
- Acute Effects of Urapidil on Airway Response in Hypertensive Patients with Chronic Obstructive Pulmonary DiseaseDrugs, 1990
- Intravenous droperidol for the treatment of status asthmaticusCritical Care Medicine, 1988
- Selective 5‐HT2 receptor blockade in exercise‐induced asthmaClinical and Experimental Allergy, 1985